A detailed history of Yousif Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Yousif Capital Management, LLC holds 86,956 shares of LLY stock, worth $69.6 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares
86,956
Previous 88,825 2.1%
Holding current value
$69.6 Million
Previous $80.4 Million 4.21%
% of portfolio
0.86%
Previous 0.93%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$772.14 - $960.02 $1.44 Million - $1.79 Million
-1,869 Reduced 2.1%
86,956 $77 Million
Q2 2024

Jul 31, 2024

SELL
$724.87 - $909.04 $2.14 Million - $2.68 Million
-2,952 Reduced 3.22%
88,825 $80.4 Million
Q1 2024

Apr 26, 2024

SELL
$592.2 - $792.28 $2.3 Million - $3.08 Million
-3,888 Reduced 4.06%
91,777 $71.4 Million
Q4 2023

Feb 01, 2024

SELL
$525.19 - $619.13 $2.05 Million - $2.42 Million
-3,905 Reduced 3.92%
95,665 $55.8 Million
Q3 2023

Oct 30, 2023

SELL
$434.7 - $599.3 $954,166 - $1.32 Million
-2,195 Reduced 2.16%
99,570 $53.5 Million
Q2 2023

Aug 02, 2023

BUY
$350.74 - $468.98 $940,684 - $1.26 Million
2,682 Added 2.71%
101,765 $47.7 Million
Q1 2023

May 02, 2023

SELL
$310.63 - $364.82 $5.27 Million - $6.19 Million
-16,954 Reduced 14.61%
99,083 $34 Million
Q4 2022

Jan 09, 2023

SELL
$321.55 - $374.67 $157,237 - $183,213
-489 Reduced 0.42%
116,037 $0
Q3 2022

Nov 04, 2022

SELL
$296.48 - $337.87 $1.69 Million - $1.93 Million
-5,713 Reduced 4.67%
116,526 $37.7 Million
Q2 2022

Aug 01, 2022

SELL
$278.73 - $327.27 $847,060 - $994,573
-3,039 Reduced 2.43%
122,239 $39.6 Million
Q1 2022

May 12, 2022

BUY
$234.69 - $291.66 $187,517 - $233,036
799 Added 0.64%
125,278 $35.9 Million
Q4 2021

Jan 31, 2022

BUY
$224.85 - $279.04 $28 Million - $34.7 Million
124,479 New
124,479 $34.4 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $760B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.